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The clinical experience of variable drug reaction is both frustrating and a stimulus to reappraisal of the action of the particular compound. The improved quality of the pharmaceutical preparations and the greater knowledge of genetic influences aided by statistical analysis have led to the development of a branch of pharmacology which is called pharmacogenetics.
In ophthalmology a pharmacogenetic concept has existed for more than a century, since the first observations in 1862 of an unusual response in certain rabbits to atropine. Fleischman in 1910 isolated atropine esterase. Attempts to implicate such an enzyme in human blood have been negative, but the concept exists that there is both a racial and an individual difference in response to mydriatics, in particular that blue irises are more responsive to mydriatics than brown.
This was tested in Caucasians, the subjects being further subdivided on the basis of the eye colour scale of Professor R Martin. Paredrine hydrobromide was the mydriatic employed, and measurements were made before application and after thirty minutes. While a bimodal trend existed, there was not statistical significance at the 95 % level. It is undoubtedly true that a racial difference occurs and this has been shown in the response of Negroes to atropine. A similar difference is not clearly shown in the response to sympathomimetics, which would indicate that this parasympatholytic variability is related to a difference in acetylcholine metabolism and perhaps unrelated to the melanin content.
An important occurrence is the sensitivity to suxamethonium bromide occasionally seen during anmsthesia (about 1/2,000-1/3,000) and possibly potentiated, in those susceptible children undergoing strabismus surgery, by pre-operative longacting miotics. The percentage inhibition of the enzyme by a local anesthetic dibucaine not only gives a method for calculation of enzyme activity but also serves to trace genetically the family sibs likely to be affected. It has been shown that a triphasic distribution occurs in pseudocholinesterase levels.
It can be postulated that some of the reactions seen after relatively large amounts of local anesthetics, particularly lignocaine, are related to the inability of serum cholinesterol to inhibit systemically absorbed local anesthetic agents. This is of particular significance in ophthalmology, where the retrobulbar anesthetic is given into an area rich in large veins; and in glaucoma surgery the patients are often potentially sensitized by their miotic regime.
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